A recombinant anti-CD38 fully human monoclonal antibody injection, HLX15 comes in both intravenous and subcutaneous formulations. Henlius will oversee development, manufacturing a ...

Sanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...

凭借对市场的敏锐洞察力和高度前瞻性,康诺亚早已在双抗这一领域积累了众多创新资产,筑牢护城河。康诺亚是国内少数拥有成熟CD3双抗研发平台的Biotech,近期达成出海的CM336和CM355即是基于CD3平台自主研发的潜力产品。

Panelists discuss how the IMROZ trial demonstrated improved outcomes with quadruplet therapy combining daratumumab, lenalidomide, melphalan, and prednisone in patients with transplant-ineligible newly ...

This is a great way to turn a smaller sized wager into a profitable payout. For example, an NHL parlay bet can work like this: On one ticket, you are placing three moneyline bets for three different ...

2025开年，医药行业接连达成数笔BD交易，其中两大单NewCo就来自康诺亚：一项是就潜在同类最优的靶向CD38人源化单克隆抗体CM313与Timberlyne Therapeutics, Inc.（以下简称Timberlyne）达成独家授权许可协议，另一项则是联合诺诚健华，就CD20xCD3双抗CM355与RTW共同创立的Newco Prolium Bioscience, ...

At the time of his retirement in 1999, Wayne Gretzky owned or shared 61 NHL records, including the mark for the most career goals. "The Great One" finished his unparalleled 20-year career with an ...

A dose expansion trial pairing up ICP-B02 with other immunochemotherapies for earlier lines of NHL treatment is also ... to take forward a clinical-stage CD38-targeting antibody.

2024年下半年，国产TCE双抗交易风靡全球，而其中与自免相关交易更是占到了所有7笔国产TCE双抗交易中的5笔，堪称“最红”的国产创新药物类型（更具体分析详见《国产新药爆红》）。 正是在这波全球药企疯抢自免TCE双抗权益的热潮中，已经有研发者开始掉队，并且还是进度最靠前的海外Biotech公司IGM Biosciences。 1月9日，IGM Biosciences宣布公司将裁员73%，并停止开发 ...

COLUMBUS / DETROIT --Today, the National Hockey League (NHL) and Fanatics, the League’s authentic outfitter, unveiled the uniforms for the 2025 Navy Federal Credit Union NHL Stadium Series ...

For every NHL team, prospects are always coming and going. As they finish off their junior, college careers or make the jump over from their European leagues, they all have the same goal ...

The Edmonton Oilers appear to be set for another Stanley Cup run. The runner-up from last year is now second in the Pacific division with a 27-13-5 record. They have 57 points, only four behind ...